Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46,037 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk of hepatitis B virus reactivation and its effect on survival in advanced hepatocellular carcinoma patients treated with hepatic arterial infusion chemotherapy and lenvatinib plus programmed death receptor-1 inhibitors.
Yang Z, Guan R, Fu Y, Hu D, Zhou Z, Chen M, Zhang Y. Yang Z, et al. Front Cell Infect Microbiol. 2024 Feb 13;14:1336619. doi: 10.3389/fcimb.2024.1336619. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38415009 Free PMC article.
Cholesterol and C-reactive protein prognostic score predicted prognosis of immune checkpoint inhibitors based interventional therapies for intermediate-to-advanced hepatocellular carcinoma patients.
Zeng H, Zhang D, Yang Z, Hu Z, Yang Z, Fu Y, Hou J, Ngai S, Wang J, Chen J, Hu D, Zhou Z, Chen M, Zhang Y, Pan Y. Zeng H, et al. Among authors: yang z. Int Immunopharmacol. 2023 Feb;115:109651. doi: 10.1016/j.intimp.2022.109651. Epub 2023 Jan 11. Int Immunopharmacol. 2023. PMID: 36638663 Free article.
Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis.
Fu Y, Peng W, Zhang W, Yang Z, Hu Z, Pang Y, Hu D, Chen J, Wang J, Zhou Z, Xu L, Chen M, Zhang Y. Fu Y, et al. Among authors: yang z. J Gastroenterol. 2023 Apr;58(4):413-424. doi: 10.1007/s00535-023-01976-x. Epub 2023 Mar 9. J Gastroenterol. 2023. PMID: 36894804
Comparable Clinical Outcomes Between Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy Combined with Tyrosine Kinase Inhibitors and PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma.
Long T, Yang Z, Zeng H, Wu W, Hu Z, Yang Z, Hu D, Zhou Z, Chen M, Zhang Y. Long T, et al. Among authors: yang z. J Hepatocell Carcinoma. 2023 Oct 20;10:1849-1859. doi: 10.2147/JHC.S436211. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 37881221 Free PMC article.
46,037 results
You have reached the last available page of results. Please see the User Guide for more information.